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Background and Objective: Although the risk of recurrent cerebral ischemia is higher
after a transient ischemic attack (TIA), there is limited data on the outcome of TIA mimics.
The goal of this study is to compare the 6-month outcome of patients with negative and
positive diffusion-weighted imaging (DWI) TIAs (DWI-neg TIA vs. DWI-pos TIA) and also
TIA mimics.
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Methods: We prospectively studied consecutive patients with an initial diagnosis of
TIA in our tertiary stroke centers in a 2-year period. Every included patient had an initial
magnetic resonance (MR) with DWI and one-, three-, and six-month follow-up visits. The
primary outcome was defined as the composition of intracerebral hemorrhage, ischemic
stroke, TIA, coronary artery disease, and death.
Results: Out of 269 patients with the initial diagnosis of TIA, 259 patients (mean age 70.5
± 15.0 [30–100] years old, 56.8% men) were included in the final analysis. Twenty-one
(8.1%, 95% confidence interval [CI] 5.1-12.1%) patients had a composite outcome event
within the six-month follow-up. Five (23.8%) and 13 (61.9%) composite outcome events
occurred in the first 30 and 90 days, respectively. Among patients with DWI-neg TIA, the
one- and six-month ischemic stroke rate was 1.5 and 4.6%, respectively. The incidence
proportion of composite outcome event was significantly higher among patients who had
the diagnosis of DWI-neg TIA compared with those who had the diagnosis of TIA mimics
(12.2 vs. 2.1%—relative risk 5.9; 95% CI, 1.4–25.2). In our univariable analysis among
patients with DWI-neg TIA and DWI-pos TIA, age (P = 0.017) was the only factor that
was significantly associated with the occurrence of the composite outcome.
Conclusion: Our study indicated that the overall six-month rate of the composite
outcome among patients DWI-neg TIA, DWI-pos TIA, and TIA mimics were 12.2, 9.7,
and 2.1%, respectively. Age was the only factor that was significantly associated with the
occurrence of the composite outcome.
Keywords: DWI-negative transient ischemic attack, transient ischemic attack mimics, DWI-positive transient
ischemic attack, composite outcome, follow-up study
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INTRODUCTION

and a different diagnosis (e.g., seizure, migraine headache) was
made. Patients with “DWI-neg TIA” diagnosis included patients
who had no alternative diagnosis or patients with probable
TIA diagnosis with negative findings in DWI. Patients with the
diagnosis of “DWI-pos TIA” had their symptoms resolved within
24 h; however, they had a positive DWI for acute ischemic stroke.
We independently reviewed each case, and final diagnoses were
made based on all the clinical information after the completion of
all follow-ups and consensus between our stroke research fellow
(AS), and one of our vascular neurologists (NE). In the absence
of a diagnostic consensus, our second vascular neurologist (RZ)
reviewed the patient medical record and acted as a tiebreaker.

After a transient ischemic attack (TIA), the risk of ischemic
stroke is high and ranging from 9 to 20% within the first 3
months (1–3). Patients suffering from TIA also have higher risks
of myocardial infarction (4), disability, and death (5, 6). A longterm outcome study of patients with TIA has shown that the
10-year risk of stroke can be up to 19% while combined outcome
risks including stroke, myocardial infarction, and death can be as
high as 43% (7).
Although there is not a widely accepted definition for TIA
mimics and there is only limited number of studies on patients
with TIA mimics (3, 8), reports are indicating that more than
50% of patients who are referred to TIA clinics are TIA mimics
(9, 10). Patients who are classified as TIA mimics have the
heterogeneous etiologies ranging from cardiac ischemic events,
dementia, strokes, to benign conditions (11, 12).
There is limited evidence on the outcome of TIA mimics. At
the same time, some of the previous TIA outcome studies used
the TIA clinical definition that alone cannot differentiate between
a DWI-neg (DWI: diffusion-weighted imaging, neg: negative)
TIA and DWI-pos (pos: positive) TIA. In this prospective study,
we aimed to assess and compare the 6-month outcome of patients
with DWI-neg TIA and TIA mimics, as well as patients with
DWI-pos TIA.

Outcome Measures
The primary outcome was defined as the composition of
intracerebral hemorrhage (ICH), ischemic stroke, TIA, coronary
artery disease (CAD), and all-cause death. Patients had an
ischemic stroke outcome when they presented with a focal
neurological deficit and a confirmatory cerebral MRI or CT Scan.
All cases of recurrent stroke and DWI-neg TIA were concluded.
Patients with ICH had confirmatory cerebral MRI or CT Scan, as
well. Patients with CAD had signs of typical chest pain confirmed
by ST-T wave changes in ECG or high blood troponin levels.
We also reviewed cardiology notes for further confirmation. We
calculated total composite outcome events for the studied cohort
in the following intervals: 30, 90, and 180 days ± 7 days following
the index event. We recorded all the patients’ medical record
information including demographics, presenting symptoms, past
medical history, medication list, clinical work-up, and imaging
study results. We calculated ABCD2 risk score for every patient
(13). We also reviewed DWI, FLAIR, T2∗ -weighted gradient
recalled echo (GRE) sequences, and CT scan. We applied Fazekas
scale for white matter lesions scoring (14, 15). This study was
part of the ongoing Geisinger stroke registry and approved by
institutional review board of Geisinger.

MATERIALS AND METHODS
We prospectively studied consecutive patients with an admission
diagnosis of TIA in one of Geisinger three tertiary stroke centers
or referral TIA diagnosis in our single TIA clinic in northeast
Pennsylvania in a 2-year period (2016–2018). Geisinger is a
comprehensive healthcare system with several hospitals and
clinics, and over one million active patients of around 90%
white ethnicity in central and northeast Pennsylvania, as well as
southeast New Jersey.

Statistical Analysis

Patient Inclusion Criteria

We summarized all continuous variables as mean ± standard
deviation (normal distribution) and as median with Inter
Quantile Range (IQR, for skewed distribution). We summarized
all categorical variables as percentages with their corresponding
95% Confidence Intervals. We applied Kruskal–Wallis test for
continuous variables. We performed statistical comparisons
between three groups using the χ2 test or, in the case of
small expected frequencies, Fisher’s exact test. We performed
multivariable analysis of logistic binary regression model. We
performed Kaplan-Meier survival analysis to evaluate “time-tocomposite outcome event” information and also the Log-Rank
statistical test was applied for evaluation of differences among
studied groups (P < 0.05). We used SPSS 24.0 (Chicago, Ill., USA)
for all our statistical analysis. Incidence rates were calculated
using MedCalc software (16).

Included patients in our study had the admission diagnosis of
TIA in one of our three tertiary stroke centers or had been
referred to our dedicated TIA clinic with the referral diagnosis
of TIA. Every included patient had an interpretable initial brain
magnetic resonance imaging (MRI). Each patient had presented
with a transient focal neurological deficit that lasted <24 h. All
hospitalized patients were evaluated by an attending neurologist
within 24 h. Every patient had either follow-up visits at our
TIA/stroke clinic or phone encounter in the following intervals:
1 month, three, and 6 months ± 7 days following the index
TIA event. We excluded patients who missed to complete the
6-month follow-up course.

Diagnostic Process
The final diagnoses of DWI-neg TIA, TIA mimics, or DWI-pos
TIA were made independent of the hospital discharge and clinic
diagnoses at the end of a 6-month follow-up period. Although
there is no clear definition for TIA mimics, we concluded patients
with “TIA mimics” when the diagnosis of TIA was ruled out,

Frontiers in Neurology | www.frontiersin.org

RESULTS
Out of 269 patients with the initial diagnosis of TIA, 259
patients (mean age 70.5 ± 15.0 [30–100] years old, 56.8% men)
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TABLE 1 | Univariate analysis comparing TIA Mimics, DWI-neg TIA, and DWI-pos TIA groups.
$ TIA mimics group

N = 97 (37.5%)

DWI-neg TIA group
N = 131 (50.6%)

DWI-pos TIA
group N = 31
(12.0%)

Total (N = 259)

P-Value

Demographic information
Gender (% of males)

63 (64.9%)

73 (55.7%)

11 (35.5%)

147 (56.8%)

0.015*

Age, mean ± SD

64.6 ± 17.0

73.7 ± 13.1

74.8 ± 11.0

70.5 ± 15.0

0.000*
0.934

Race
94 (96.9%)

128 (97.7%)

30 (96.8%)

252 (97.3%)

African-American

White

2 (2.1%)

3 (2.3%)

1 (3.2%)

6 (2.3%)

Patient declined to provide

1 (1.0%)

0 (0.0%)

0 (0.0%)

1 (0.4%)

Past medical history
Diabetes mellitus

26 (26.8%)

45 (34.4%)

9 (29.0%)

80

0.462

Hypertension

60 (61.9%)

113 (86.3%)

26 (83.9%)

199

0.000*

Atrial fibrillation, PAF† , flutter

9 (9.3%)

26 (19.8%)

8 (25.8%)

43

0.036*

Hyperlipidemia

66 (68.0%)

117 (89.3%)

27 (87.1%)

210

0.000*

Previous history of stroke

19 (19.6%)

35 (26.7%)

9 (29.0%)

63

0.375

Previous history of TIA

27 (27.8%)

35 (26.7%)

6 (19.4%)

68

0.637

6 (6.2%)

20 (15.3%)

5 (16.1%)

31

0.085
0.033*

Peripheral vascular disease
Coronary artery disease (CAD)

29 (29.9%)

61 (46.6%)

14 (45.2%)

104

Patent foramen ovale

7 (21.2%)

14 (22.2%)

2 (14.3%)

23

0.803

Intracranial arterial disease

16 (25.0%)

44 (48.9%)

13 (50.0%)

73

0.007*

COPD‡

14 (14.4%)

28 (21.4%)

5 (16.1%)

47

0.386

43 (44.3%)

66 (50.4%)

14 (45.2%)

123

0.011*

6 (6.2%)

17 (13.0%)

5 (16.1%)

28

Carotid disease
<50% Stenosis
50–70% Stenosis

0 (0.0%)

7 (5.3%)

3 (9.7%)

10

Tobacco use

>70% Stenosis

22 (22.7%)

31 (23.7%)

3 (9.7%)

56

Alcohol use

25 (25.8%)

43 (32.8%)

8 (25.8%)

76

0.461

Seizure disorder

10 (10.3%)

1 (0.8%)

0 (0.0%)

11

0.001*

Migraine

0.007*

0.224

20 (20.6%)

10 (7.6%)

2 (6.5%)

32

Autoimmune disease

0 (0.0%)

5 (3.8%)

0 (0.0%)

5

0.083

Coagulation disorders

5 (5.2%)

7 (5.3%)

1 (3.2%)

13

0.886

History of cancer

17 (17.5%)

31 (23.7%)

9 (29.0%)

57

0.327

Kidney disease

19 (19.6%)

32 (24.4%)

8 (25.8%)

59

0.630

Currently on dialysis

0 (0.0%)

1 (0.8%)

0 (0.0%)

1

0.612

Psychiatric illness

48 (49.5%)

44 (33.6%)

7 (22.6%)

99

0.008*

Antiplatelet use (pre-hospitalization)

49 (50.5%)

86 (65.6%)

21 (67.7%)

156

0.046*

7 (7.2%)

16 (12.2%)

3 (9.7%)

26

0.462

Oral anticoagulant (prehospitalization)
Emergency department presentation symptoms
Altered mental status

16 (16.5%)

29 (22.1%)

5 (16.1%)

50

0.505

Headache

25 (25.8%)

23 (17.6%)

7 (22.6%)

55

0.319

Loss of consciousness

3 (3.1%)

1 (0.8%)

1 (3.2%)

5

0.385

Generalized weakness

11 (11.3%)

13 (9.9%)

6 (19.4%)

30

0.335

Unilateral arm weakness

26 (26.8%)

32 (24.4%)

12 (38.7%)

70

0.273

Unilateral leg weakness

23 (23.7%)

26 (19.8%)

9 (29.0%)

58

0.504

Expressive aphasia

15 (15.5%)

28 (21.4%)

8 (25.8%)

51

0.356

Dysarthria

23 (23.7%)

51 (38.9%)

11 (35.5%)

85

0.051

Facial droop

14 (14.4%)

29 (22.1%)

7 (22.6%)

50

0.306

Unilateral arm numbness

43 (44.3%)

40 (30.5%)

9 (29.0%)

92

0.071

Unilateral leg numbness

23 (23.7%)

23 (17.6%)

7 (22.6%)

53

0.498

Facial numbness

26 (26.8%)

42 (32.1%)

3 (9.7%)

71

0.042*
(Continued)
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TABLE 1 | Continued
$ TIA mimics group

DWI-neg TIA group
N = 131 (50.6%)

DWI-pos TIA
group N = 31
(12.0%)

Total (N = 259)

P-Value

N = 97 (37.5%)

Sudden true vertigo

9 (9.3%)

2 (1.5%)

0 (0.0%)

11

0.007*

Diplopia

1 (1.0%)

4 (3.1%)

0 (0.0%)

5

0.387

19 (19.6%)

12 (9.2%)

3 (9.7%)

34

0.058

Hemianopsia
Mono-ocular blindness
Ataxia
Seizure like activity

0 (0.0%)

2 (1.5%)

1 (3.2%)

3

0.294

13 (13.4%)

17 (13.0%)

5 (16.1%)

35

0.898

3 (3.1%)

1 (0.8%)

1 (3.2%)

5

0.385

13 (13.4%)

21 (16.0%)

6 (19.4%)

40

0.702

Visual Aura

4 (4.1%)

3 (2.3%)

0 (0.0%)

7

0.429

Amnesia

6 (6.2%)

9 (6.9%)

3 (9.7%)

18

0.800

Length of hospitalization (days), mean
± SD

1.9 ± 1.8

2.0 ± 1.5

4.0 ± 2.3

2.2 ± 1.8

0.000*

Duration of symptoms (minutes), mean
± SD

140.8 ± 258.2

191.7 ± 339.2

420.7 ± 481.7

207.9 ± 350.1

0.001*

24 (29.3%)

42 (43.3%)

10 (33.3%)

76

0.006*

Moderate

22 (26.8%)

28 (28.9%)

10 (33.3%)

60

Severe

12 (14.6%)

16 (16.5%)

9 (30.0%)

37

≤3

63 (64.9%)

58 (44.3%)

5 (16.1%)

126

3<

34 (35.1%)

73 (55.7%)

26 (83.9%)

133

Pre-syncope

Imaging study results
WMDU on MRI Fazekas score
Low

§ ABCD2 Score

0.000*

Discharged patients’ medications
77 (79%)

131 (100%)

31 (100%)

239

0.000*

Anti-cholesterol therapy

Antiplatelet/anticoagulation therapy

66 (68.0%)

117 (89.3%)

27 (87.1%)

210

0.000*

Antihypertensive therapy

60 (61.9%)

113 (86.3%)

26 (83.9%)

199

0.000*

$ TIA,

Transient ischemic attack.
(Age, Blood pressure, Clinical, Duration, Diabetes).

§ ABCD2 ,

†

PAF, Paroxysmal atrial fibrillation.

‡

COPD, Chronic obstructive pulmonary disease.
White matter disease.
*P < 0.05, Statistically meaningful.
U WMD,

Out of 259 patients, 21 (8.1%, 95% confidence interval [CI]
5.1–12.1%) patients had a composite outcome event within the
6-month follow-up. Although several patients had readmission
for other reasons, we did not have any patient who had more
than one composite outcome event during the 6 months followup. Five (23.8%) and 13 (61.9%) composite outcome events
occurred in the first 30 and 90 days, respectively (Table 2).
We also observed 8 (38.1%) composite outcome events in the
second 90 days (Figure 2). Overall, patients with a diagnosis of
DWI-neg TIA had a higher rate (12.2%) of composite outcome
events followed by DWI-pos TIA (9.7%) and TIA mimics cohort
(2.1%) (Table 3).

were included in the final analysis (Table 1). Ten patients (2
patients with a diagnosis of TIA mimics and 8 patients with
a diagnosis of DWI-neg TIA) who missed to complete 180
days follow-up course were excluded. Out of 259 patients, 97
(37.4%) patients had the diagnosis of TIA mimics, 131 (50.6%)
patients had a DWI-neg TIA diagnosis, and 31 (12.0%) patients
had the diagnosis of DWI-pos TIA. Carotid endarterectomy
was performed only for three (1.2%) patients in the group of
DWI-neg TIA. The most common alternative diagnosis in the
TIA mimics group was toxic/metabolic diseases followed by
migraine (Figure 1).
Among studied cohort (N = 259), the univariate
analysis revealed a significant difference (P <
0.05)
among the three groups (TIA mimics, DWI-neg TIA, and
DWI-pos TIA) in terms of age, history of hypertension,
atrial fibrillation, hyperlipidemia, coronary artery disease,
intracranial arterial disease, psychiatric illness, carotid
disease, and antiplatelet use (Table 1). Patients with DWIpos TIA had longer symptoms’ duration and higher ABCD2
score (Table 1).

Frontiers in Neurology | www.frontiersin.org

Outcome Events in Patients With the
Diagnosis of TIA Mimics
The overall composite outcome rate was 2.1% (2 out of
97 patients) in this group. There was not any composite
outcome event in the first 30 days after initial admission.
There was only one composite outcome event (CAD) in
the first 90 days followed by one composite outcome event
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FIGURE 1 | Alternative diagnoses of TIA Mimics patients.

TABLE 2 | Composite outcome events in early and late intervals.
30 days composite
outcome events

First 90 days composite
outcome events

Second 90 days composite
outcome events

Number of composite outcome events in
TIA mimics patients (N = 2)

0

1

1

Number of composite outcome events in
DWI-neg TIA patients (N = 16)

3

9

7

Number of composite outcome events in
DWI-pos TIA patients (N = 3)

2

3

0

Total (N = 21)

5

13

8

FIGURE 2 | Timeline of composite outcomes.
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6

0.2–47.0
2.7
0.0
3.8
0.0–24.4
1.0
1.0
0.0
0.4–31.2

*All incidence proportions are in percentage.
** Statistically meaningful.

1.0
3.8

3.7

0.0–1.6
0.1–24.6
0.2
1.2
6.5
0.0
1.5
1.5
0.8–310.7
0.0–24.4
15.3
1.0
0.0
1.0
6.5
0.0
0.2–76.5
0.1–16.1
0.0
1.0
1.5
1.5

3.7
1.5

0.0–17.4
0.7
0.0
0.8
0.1–151.2
3.1
0.0
0.0
0.1–54.1
0.0
0.8

2.2

0.2–11.4
1.4
3.2
4.6
0.4–220.0
9.2
0.0
3.2
0.6–169.3
9.7

1.3
9.7
12.2
0.8–26.8
4.7
2.1
9.7

Incidence
proportions
in DWI-pos
TIA patients
95%
confidence
interval
Relative risk
Incidence
proportions
in TIA
mimics
patients

0.0

In our study, the overall six-month rate of the composite outcome
(ICH, ischemic stroke, TIA, CAD, and all-caused death) among
patients with DWI-neg TIA, DWI-pos TIA, and TIA mimic
were 12.2, 9.7, and 2.1%, respectively. The six-month rate of the
composite outcome of combined DWI-neg TIA and DWI-pos
TIA was 11.7%. More than half of composite outcome events

4.6

DISCUSSION

*Incidence
proportions
in DWI-neg
TIA patients

TABLE 3 | Outcome incidence proportions in 180 days follow-up course for studied cohort.

Incidence
proportions
in TIA
mimics
patients

Relative risk

95%
confidence
interval

The composite outcome rate was 9.7% (3 out of 31 patients)
among patients with DWI-pos TIA. There was no death in this
group. We had one patient with TIA outcome event on day 4 after
initial admission. We had only one (3.2%) patient with recurrent
ischemic stroke outcome event (Table 3).
The incidence proportion of composite outcome event was
higher among patients who had the diagnosis of DWI-neg TIA
compared with those who had the diagnosis of TIA mimics (12.2
vs. 2.1%), the difference was significant (relative risk 5.9; 95%
CI, 1.4–25.2). Although there was not a significant difference in
the incidence proportion of composite outcome events between
patients with the diagnosis of DWI-pos TIA and patients with
TIA mimics (relative risk 4.7; 95% CI, 0.82–26.8), there was a
trend for a higher rate of composite outcome events in patients
with DWI-pos TIA (9.7 vs. 2.1%) (Table 3).
We performed a univariable analysis among patients with
DWI-neg TIA and DWI-pos TIA (Table 4). Although we
observed a higher rate of hypertension (P = 0.078), the severity
of white matter disease (P = 0.076), and peripheral vascular
disease (P = 0.082) among patients with the positive composite
outcome, the difference was not significant. In our analysis,
age (P = 0.017) was the only factor that was significantly
associated with the occurrence of the composite outcome. We
performed a multivariable binary logistic regression analysis
for our composite outcomes based on univariable analysis
results. All variables with P < 0.15 (Table 4) in the univariate
model including: age, hypertension, peripheral vascular disease,
intracranial arterial disease, seizure disorder, and white matter
disease were included in the model. None of the variables
including age was found to be significantly associated with
the outcome.

1.4–25.2**

Outcome Events in Patients With the
Diagnosis of DWI-pos TIA

5.9

Incidence
proportions
in DWI-neg
TIA patients

Incidence
proportions
in DWI-pos
TIA patients

The overall composite outcome rate was 12.2% (16 out of 131
patients) in this group. More than half of the composite outcome
events (9 events; 56.3%) occurred in the first 90 days. The single
ICH outcome event occurred in this cohort. Our earliest outcome
event (ischemic stroke) occurred on day 4. The one-month and
six-month ischemic stroke rate was 1.5 and 4.6%, respectively.
The one-month and six-month mortality rate were 0.0 and 3.8%,
respectively (Table 3).

2.1

Relative risk

Outcome Events in Patients With the
Diagnosis of DWI-neg TIA

12.2

95%
confidence
interval

of death due to cancer in the second 90 days (97th
day) (Figure 3).

0.4–4.1

Outcome of Transient Ischemic Attack and Its Mimics

OUTCOME
Composite
outcome
Ischemic
stroke
Intracranial
hemorrhage
(ICH)
TIA
Coronary
artery disease
(CAD)
All cause
death
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FIGURE 3 | Kaplan-Meier estimates of composite outcomes.

occurred within 3 months following the index event. Patients
with TIA mimics had no stroke or ICH event at 6 months followup course. Our results highlight the value of a multi-resolution
view, where high-fidelity data at multiple time points are used,
for better identification of more efficient care plans for this at-risk
patient population.
Over the past few decades, there have been multiple studies
measuring the rate of stroke following a TIA event. Older studies
indicated a range of 9–15% (17–20) within 3 months after a TIA
event; however, newer studies reported a lower range of 0.9–
4.3% (8, 21–23). In our cohort, patients with DWI-neg TIA had
4.6% risk stroke occurrence at 6 months. Although there has
been considerable heterogeneity among studies due to different
TIA phenotype and outcome definition, the calculated risk of
stroke (4.6%) in our study is similar to recent studies. There
are limited literature on TIA mimics; however, we found two
studies (3, 8), that evaluated the outcome of patients with a
TIA mimics. Our TIA mimics patients had no stroke outcome
event at 6 months follow-up course which was similar to the 3
months TIA mimics outcome results in the other two studies
(3, 8). Our TIA mimics patients had a composite outcome
rate of 2.1% at 6 months including 1.0% all-cause death rate
and 1.0% CAD that were closely similar to the retrospective
study by Dutta et al. (8) with the all-cause death rate of
0.6% and CAD rate of 0.6% at 3 months follow-up course.
It is noteworthy that the lack of a widely approved definition
for TIA mimics and heterogeneous nature of TIA mimics

Frontiers in Neurology | www.frontiersin.org

should be taken into account for interpretation of outcome in
different studies.
The decremental trend of the cerebral ischemia recurrence
could be attributed to the changes in the definition of TIA, better
secondary prevention, and faster evaluation of TIA patients (24).
Recent studies have shown that over the past decade patients with
primary TIA or stroke in developed countries are older probably
due to improved primary prevention. The concept of rapid access
TIA clinic or urgent in-hospital care might have also played an
important role in reducing recurrent ischemic events.
In our study, patients with DWI-pos TIA had a 9.7% rate
of the composite outcome within 6 months follow-up course.
Comparison of our results with 1-year outcome assessment of a
large international cohort (22) shows a barely similar composite
outcome rate (6.2%). One important difference between these
two studies is that we used MRI to differentiate between DWIpos TIA and DWI-neg TIA while in the other study a mixed pool
of DWI-neg TIA or DWI-pos TIA patients were considered for
outcome assessment. We did not have any death during the 6month follow-up course while in the other study all-cause death
rate was 1.8%. This difference could be easily attributed to the
studied population size and longer follow-up course. The most
common single outcome event in our DWI-pos TIA patients was
TIA (6.5%) which was similar to the other study result (7.4%).
As it has shown in our study and other studies, patients with
DWI-pos TIA or DWI-neg TIA have the highest risk of recurrent
ischemic stroke event in the first 30 and 90 days following index
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TABLE 4 | Univariate analysis: composite outcome and associated factors among patients with DWI-neg TIA and DWI-pos TIA.
Negative outcome event N = 143

Positive outcome event N = 19

Gender (% of males)

72 (50.3%)

12 (63.2%)

0.336

Age, mean ± SD

73.1 ± 12.8

80.4 ± 8.5

0.017*

P-Value

Demographic Information

Past medical history
Diabetes mellitus

45 (31.5%)

9 (47.4%)

0.198

Hypertension

120 (83.9%)

19 (100%)

0.078

Atrial fibrillation, PAF† , flutter

25 (20.3%)

5 (26.3%)

0.553

Hyperlipidemia

126 (88.1%)

18 (94.7%)

0.698

Previous history of stroke

36 (25.2%)

8 (41.2%)

0.167

Previous history of TIA

36 (25.2%)

5 (26.3%)

0.999

Peripheral vascular disease

19 (13.3%)

6 (31.6%)

0.082

Coronary artery disease (CAD)

64 (44.8%)

11 (57.9%)

0.332

Patent foramen ovale

14 (20.3%)

2 (25%)

0.668

Intracranial arterial disease

46 (46.0%)

11 (68.8%)

0.111

COPD‡

29 (20.3%)

4 (21.1%)

0.999

<50% Stenosis

69 (48.3%)

11 (57.9%)

0.191

50–70% Stenosis

18 (12.6%)

4 (21.1%)

Carotid disease

8 (5.6%)

2 (10.5%)

Tobacco use

>70% Stenosis

30 (21.0%)

4 (21.1%)

0.999

Alcohol use

47 (32.9%)

4 (21.1%)

0.431

Seizure disorder

0 (0.0%)

1 (5.3%)

0.117

Migraine

10 (7.0%)

2 (10.5%)

0.635

Autoimmune disease

5 (3.5%)

0 (0.0%)

0.999

Coagulation disorders

8 (5.6%)

0 (0.0%)

0.598

History of cancer

33 (23.1%)

7 (36.8%)

0.255

Kidney disease

33 (23.1%)

7 (36.8%)

0.255

1 (0.7%)

0 (0.0%)

0.999

43 (30.1%)

8 (42.1%)

0.302

Antiplatelet use (pre-hospitalization)

93 (65.0%)

14 (73.7%)

0.608

Oral anticoagulant (pre-hospitalization)

17 (11.9%)

2 (10.5%)

0.999

0.076

Currently on dialysis
Psychiatric illness

Imaging study results
WMDU on MRI Fazekas score
Low

47 (43.1%)

5 (27.8%)

Moderate

32 (29.4%)

6 (33.3%)

Severe

18 (16.5%)

7 (38.9%)

§ ABCD2 score

≤3

58 (40.6%)

5 (26.3%)

3<

85 (59.4%)

14 (73.7%)

§ ABCD2 ,

†
‡

0.318

(Age, Blood pressure, Clinical, Duration, Diabetes).

PAF, Paroxysmal Atrial Fibrillation.
COPD, Chronic Obstructive Pulmonary Disease; U WMD, White Matter Disease.

event (25), this highlights the importance of rapid and proper
evaluation and treatment of the initial ischemic event. The role
of hypertension as an important modifiable risk factor for stroke
has been known, however, in recent metanalysis hypertension is
found to be the most important modifiable risk factor for stroke
recurrence, as well (26). In our cohort, we had a meaningful
difference among patients with diagnoses of DWI-neg TIA and
DWI-neg TIA and patients with a TIA mimic in terms of

Frontiers in Neurology | www.frontiersin.org

hypertension. We also observed a higher rate of hypertension
(P = 0.078) among patients with an outcome event; however,
the difference did not reach a significant level. Taken altogether,
strict hypertension control along with other modifiable risks
management in the early phase after index event could take a
unique role in the secondary stroke prevention. Although in our
cohort more than 60% of our composite outcome events occurred
in the first 90 days, which is consistent with previous studies,
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strength of this study due to reduced heterogeneity and higher
degrees of generalizability to a similar population.
In conclusion, our study indicated that the overall six-month
rate of the composite outcome (ICH, ischemic stroke, TIA, CAD,
and all-cause death) among patients with DWI-neg TIA, DWIpos TIA, and TIA mimics were 12.2, 9.7, and 2.1%, respectively.
More than half of the composite outcome events occurred within
90 days following the index event. Age was the only factor
that was significantly associated with the occurrence of the
composite outcome.

we still need to answer an important question about the value of
risk factor modification beyond the early follow-up course (27).
Finally, the multi-resolution design in this study was important
to draw some of these important conclusions.
Although evaluation of the outcome among patients with
diagnosis of TIA mimics, considering the heterogenic nature of
the condition, is difficult, the very low rate of adverse outcome
among patients in this group can be clinically important. It
can further highlight the importance of triaging, and proper
diagnosis of these patients as many of these patients might not
require urgent clinical evaluation and hospitalization. Some of
our patients in this group had the alternative diagnoses of toxic
or metabolic encephalopathy that encompasses a wide variety
of diseases that require a different treatment plan. The main
etiology of single death outcome event in this group was cancer,
not cerebrovascular disease; however, the most frequently defined
alternative diagnosis was migraine similar to a previous report
(28). Altogether, it suggests that outcome study in TIA mimics
is challenging however it confirms that majority of these patients
might not benefit from a hospital admission.
The ABCD2 score has been widely used, since its introduction,
in the primary care setting for identification of the patients who
have a higher risk of stroke recurrence. Although we found
a significantly lower ABCD2 score among patients with TIA
mimics, the score failed to predict the risk of the composite
outcome occurrence at 6 months. Our finding is similar to the
results of recent studies (29, 30), which showed that the ABCD2
score might not be a reliable tool to define a higher risk of the
recurrent stroke.
Our study has some limitations. Although the patients were
recruited from different hospitals in rural and urban areas
in central and northeast Pennsylvania, the study was a single
healthcare system study. We had a relatively small sample
size with lack of ethnic diversity in the study population.
Nevertheless, the lack of diversity could also be considered as a
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